Then, MTT assay showed that the inhibition of FUCA2 could significantly reduce the cell viability of lung cancer cell lines A549 (Figure 10B) and NCI-H1299 (Figure 10D), which was consistent with our conclusion. This evidence concerns the gene FUCA2 and lung carcinoma.